Fogarty International Center
-
Novel way to neutralize Rift Valley Fever Virus
The discovery of monoclonal antibodies that neutralize Rift Valley Fever Virus — an emerging infection with pandemic potential — lays the foundation for future therapeutic antibody development. Read MoreApr 1, 2021
-
Preserving NIH’s Fogarty International Center crucial for global health efforts
This week Douglas Heimburger, M.D., M.S., professor of Medicine at Vanderbilt, joined a growing chorus calling for preservation of the Fogarty International Center of the National Institutes of Health (NIH). Read MoreMay 26, 2017
-
Grants bolster HIV-focused research capacity
The Vanderbilt Institute for Global Health (VIGH) has received two new grants from the Fogarty International Center of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Zambia, Mozambique and Brazil. Read MoreAug 20, 2015
-
VUSM student receives AMA Foundation Minority Scholars Award
The American Medical Association (AMA) Foundation and the AMA Minority Affairs Section recently named Dagoberto Ordonez, a second-year medical student at Vanderbilt University School of Medicine, a 2015 AMA Foundation Minority Scholars Award recipient. Read MoreJun 25, 2015
-
‘Acid test’ for cervical cancer
An inexpensive, low-tech test for cervical cancer may be a good option for screening for the disease among HIV-infected women in developing countries. Read MoreFeb 21, 2012